BioMap, supported by Baidu, has confidentially submitted plans for an initial public offering in Hong Kong, aiming to raise several hundred million dollars this year. Bloomberg posted on X, citing sources familiar with the matter. The company is preparing to tap into the financial markets to bolster its growth and development initiatives. The move comes as BioMap seeks to expand its operations and enhance its market presence. Further details about the IPO, including the exact timing and valuation, remain undisclosed.
Original and detailed news is here: Read More
